{
  "ticker": "GLH",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02973074",
  "id": "02973074",
  "pages": 12,
  "price_sensitive": true,
  "date": "20250728",
  "time": "0835",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250728/pdf/06m63hrq0xgymq.pdf",
  "summary": "### **Quarterly Report (Appendix 4C) Summary**  \n\n**Financial & Operational Highlights:**  \n- **Sales orders**: $700K in Jun-25 quarter; FY25 new sales up 65% YoY to $2.4M.  \n- **ARR growth**: SaaS platforms now 30% of total ARR ($2.4M annual backlog for FY26 delivery).  \n- **R&D reduction**: Down 20% QoQ and 30% YoY ($2.1M FY25 vs. $2.7M FY24); $700K government rebate expected.  \n- **AI focus**: Productivity gains achieved; integration into products underway.  \n- **Cash balance**: $1.383M (up 66% QoQ); net operating cash flow +$397K.  \n- **Debt facilities**: $1.569M drawn (of $1.804M total), including convertible notes ($946K at 12% p.a.).  \n\n**Forward Targets:**  \n- Return to profitability and cash flow positivity by Jun-2026.  \n- R&D to taper to ~18% of expenses, shifting focus to AI and market expansion.  \n\n**Sector Risks:**  \n- Public/private healthcare funding pressures persist (labor, energy costs, occupancy uncertainty).  \n\n*No material capital raising or corporate action disclosed.*",
  "usage": {
    "prompt_tokens": 4822,
    "completion_tokens": 281,
    "total_tokens": 5103,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-27T22:57:43.047075"
}